Skip to content

Author

Akash Jaiswal

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 15267: Efficacy and Safety of Combination Therapy with GLP-1 and SGLT2 Inhibitors versus GLP-1 Monotherapy in Patients with Type 2 Diabetes and Heart Failure with Preserved Ejection Fraction (HFpEF)

Background: According to the European Society of Cardiology (ESC) guidelines, both GLP-1 receptor agonists and SGLT2 inhibitors have documented cardiovascular benefits in patients with type 2 diabetes mellitus (T2DM), with SGLT2 inhibitors particularly recommended to reduce heart failure hospitalizations. However, r...

Vikash Jaiswal, M. Banach, Akash Jaiswal et al. · 0 citations
Nov 2026

Abstract 14707: Synergistic Cardiovascular Benefits of Combined GLP-1 Receptor Agonists and SGLT2 Inhibitors versus SGLT2 Inhibitor Monotherapy in Patients with Type 2 Diabetes and HFpEF

Background: Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) provide cardiovascular benefits in type 2 diabetes (T2D). While SGLT2i is a cornerstone therapy for heart failure with preserved ejection fraction (HFpEF), the incremental prognostic benefit of...

A. Bielecka-Dąbrowa, M. Banach, Akash Jaiswal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.